{"id":1274097,"title":"DSEN Abstract: High potency statins and the risk of new diabetes - CIHR","sourceCode":"cihr","sourceName":"Canadian Institutes of Health Research","language":"en","captureDate":"2026-03-28","captureTimestamp":"2026-03-28T05:19:15.042000+00:00","jobId":8,"originalUrl":"https://cihr-irsc.gc.ca/e/49225.html?wbdisable=false","snippet":"DSEN Abstract High potency statins and the risk of new diabetes This research was funded by the Drug Safety and Effectiveness Network (DSEN) and conducted by the following investigators: Colin R. Dormuth, Kristian B. Filion, J. Michael Paterson, Matthew T. James, Gary F. Teare,…","rawSnapshotUrl":"/api/snapshots/raw/1274097","browseUrl":"https://replay.healtharchive.ca/job-8/20260328051915/https://cihr-irsc.gc.ca/e/49225.html?wbdisable=false#ha_snapshot=1274097","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}